Opsoclonus After COVID-19 in an Infant - 24/03/21
Conflicts of Interest/Financial Disclosure: No conflicts for any author related to this Case report. |
|
For completeness: Dr. Arnold is President of Glacier Medical Software that makes cloud-based NICU monitoring ROP-Check and also President of PDI Check that makes a patent-pending vision screening game for the autostereoscopic Nintendo 3DS console. Dr. Arnold coordinates the Alaska Blind Child Discovery, which has received discounted vision screening technology from several vendors. Dr. Arnold is an investigator and protocol developer for the NIH-funded Pediatric Eye Disease Investigator Group. |
|
Institutional Review Board: Pacific. |
|
Clinical Trials Registry: n/a. |
|
Data Access: n/a. |
|
Contributor’s Statement Page: All authors collected data, contributed to writing and critical review, and gave approval. Darion L. Heald, BS, MSIII, Irisa M Devine, MD, Roderic L. Smith, MD, PhD, Sarah A.T. Holsopple, MD, Jessica L. Arasmith, MD, and Robert W. Arnold, MD, FAAP, collected data, drafted, and helped revise article; gave final approval to this version; and agreed to be accountable for all aspects of this work. |
Vol 117
P. 34 - avril 2021 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.